So my dad got diagnosed with stage IV pleural meso in March and we spent about six weeks just trying to figure out if a trial made sense at all. I'm an NP so I was pulling studies at midnight like some kind of obsessed person and honestly a lot of what's out there is either too vague or assumes you've already got a medical team helping you filter.
Here's what actually matters when you're looking at trials and you don't have months to waste.
First, the trial's actual endpoint. Some are looking at overall survival, some are looking at response rate or progression-free survival. These sound similar but they're not. If the trial is measuring something like "percentage of people who respond" that's different from "how long people live." For my dad's situation, we prioritized survival data because he was already palliative by the time we looked at this stuff. A trial measuring tumor shrinkage alone wasn't going to change our conversation.
Second, eligibility criteria that actually apply to your person. I cannot stress this enough. My dad's creatinine was slightly elevated and we got rejected from two trials before even talking to the teams. I should have just asked upfront, "what are your hard cutoffs for kidney function and liver function" instead of getting his hopes up. Read the inclusion and exclusion criteria like it's a contract because it basically is.
Third, the trial location and frequency. Stage IV patients are already exhausted. If the trial requires weekly visits to a center three hours away, that's a real barrier even if the drug sounds promising. My dad was at Northwestern doing palliative care and there was a trial at Lurie Children's that looked good on paper but required twice-weekly visits. That wasn't realistic.
Fourth, whether they're still enrolling and what the actual enrollment status is. I found several trials that looked perfect and then called and they weren't taking new patients anymore or they'd hit their enrollment cap. The website didn't say that clearly. Always call and ask directly, "are you actively enrolling right now and how soon do you need to start."
Fifth, what happens after the trial ends. This one nobody talks about. If your person responds well, can they stay on the drug. If they don't respond, what's the plan. For palliative patients especially, you need to know if the trial is just extending a difficult process or if there's actually a pathway to continued treatment.
We ended up not doing a trial because by the time we got through the screening process for the ones that seemed viable, my dad's performance status had declined enough that he wouldn't have tolerated it. But if we'd asked these questions earlier and had a medical team actually helping us filter instead of me doing it alone at 2am, we might have made a different call.
The oncology team should be helping you with this. If they're not, that's a red flag. My dad's palliative care doc at Northwestern was incredible about just saying "here are the three trials I think are worth your time" instead of leaving us to swim through ClinicalTrials.gov.
Anyway, if you're looking at trials right now, start with the eligibility criteria first. Don't fall in love with a drug until you know your person actually qualifies.